If you have been reading about LC-MS and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-10-23. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory identification of NMN usually relies on chromatographic separation coupled with ultraviolet or mass spectrometric detection. High-performance liquid chromatography with UV absorbance can quantify the compound against a reference standard, while liquid chromatography-tandem mass spectrometry offers lower detection limits and better specificity in complex matrices. Nuclear magnetic resonance spectroscopy can confirm structural identity and isomeric form. Ion chromatography or capillary electrophoresis may be used to identify counterions such as sodium. Method validation includes accuracy, precision, linearity, and limits of detection.
Stability testing examines how temperature, humidity, light, and pH affect NMN over time. The compound is generally stored cold, often at minus twenty degrees Celsius or lower, in a desiccated container protected from light. Aqueous solutions tend to be less stable than dry powder because hydrolysis and dephosphorylation can occur, potentially forming nicotinamide riboside or other degradation products. Stress studies may expose samples to heat, acid, base, oxidation, and strong light to identify likely degradation pathways. Results from such studies help define shelf life and handling recommendations, though exact stability depends on formulation and packaging.
Solid NMN is generally handled as a moisture-sensitive compound. Dry material stored desiccated at low temperature, protected from light, tends to remain stable for extended periods. Aqueous solutions are less stable and can undergo hydrolysis, especially at elevated temperature or alkaline pH. The anomeric form also matters: beta-NMN is the naturally occurring form, while alpha-NMN can appear as a synthetic impurity. Purity and storage conditions therefore influence both analytical results and experimental reproducibility.
Identity and purity are usually assessed with complementary methods. Nuclear magnetic resonance spectroscopy can confirm the molecular structure and distinguish anomeric forms. High-performance liquid chromatography with ultraviolet detection or mass spectrometry is common for assay and related-substance testing. Mass spectrometry also supports trace quantification in biological samples, often with isotope-labeled internal standards. Because NMN lacks a strong chromophore, some ultraviolet methods require careful wavelength selection or derivatization, and laboratories may validate each approach for its intended matrix.
Commercial NMN is produced through enzymatic or chemical routes, and the resulting material can vary in purity, counterion, and residual solvent content. Buyers typically rely on certificates of analysis, but independent verification through third-party laboratories provides stronger assurance. Regulatory treatment differs by country; in the United States, NMN has been subject to shifting guidance about its status as a dietary supplement, while other markets permit sales under local rules. No universal pharmacopeial monograph exists for NMN, so specifications often come from suppliers, research protocols, or regional requirements.
| Property | Value | Notes |
|---|---|---|
| Typical assay method | HPLC with UV detection | Often at 254 or 260 nm; LC-MS/MS used for trace analysis. |
| Storage temperature | -20 °C or below | Dry powder; protect from light and moisture. |
| Aqueous stability | Limited | Solutions may hydrolyze or dephosphorylate; prepare fresh when possible. |
| Counterion check | Ion chromatography | Identifies sodium or other counterions in salt forms. |
| Common related impurities | Nicotinamide, nicotinamide riboside, NAD+ | Monitored by chromatographic purity methods. |
Analytical laboratories identify and quantify NMN using several complementary techniques. High-performance liquid chromatography with ultraviolet detection is widely used for purity and assay work. Liquid chromatography coupled to mass spectrometry provides greater sensitivity and is common for biological matrices. Nuclear magnetic resonance spectroscopy supports structural confirmation and can distinguish related nucleotides. Accurate measurement depends on reference standards, validated methods, and careful sample preparation, especially because NMN can convert to related compounds under some conditions.
Regulatory treatment of NMN varies by jurisdiction and has changed over time. Some countries allow it in dietary supplements, while others treat it as a novel food ingredient requiring safety review. In the United States, the Food and Drug Administration has questioned whether NMN can be lawfully marketed as a dietary supplement because of drug preclusion provisions. Sports organizations have separate rules, and NMN is not currently on the World Anti-Doping Agency prohibited list. These differences create uncertainty for manufacturers, retailers, and researchers seeking consistent legal pathways.
Solid NMN is a polar, water-soluble nucleotide that can absorb moisture from air. Its phosphate ester is susceptible to hydrolysis, and degradation is faster in aqueous solution, under strongly acidic or alkaline conditions, and at elevated temperatures. For laboratory and commercial handling, the solid is typically kept desiccated, protected from light, and stored frozen. Repeated freeze-thaw cycles can introduce moisture and accelerate breakdown. Stability data for specific formulations should be generated rather than assumed from the parent compound.
Identity and purity of NMN are commonly assessed by liquid chromatography with ultraviolet detection or mass spectrometry. High-performance liquid chromatography can separate related impurities such as nicotinamide, nicotinamide riboside, and NAD+ depending on the method. Mass spectrometry provides molecular mass confirmation, while nuclear magnetic resonance spectroscopy helps establish structure and anomeric form. Quantitative assays often use calibration curves and, in biological samples, stable isotope-labeled internal standards. Method validation addresses specificity, linearity, accuracy, precision, and limits of detection.
Quality control for NMN materials typically includes appearance, assay, impurity profile, residual solvents, heavy metals, and microbial limits. A certificate of analysis summarizes specified tests, but the underlying methods and laboratory accreditation matter. Regulatory treatment varies by country; NMN is sold as a dietary supplement in some markets, while other jurisdictions restrict its use in foods or classify it differently. Independent verification can reduce risks of mislabeling or substitution. Questions remain about how product purity, storage history, and formulation affect delivered dose in humans.
Common laboratory methods for NMN include high-performance liquid chromatography with ultraviolet detection, liquid chromatography coupled to mass spectrometry, and nuclear magnetic resonance spectroscopy. Because the nicotinamide ring absorbs ultraviolet light, HPLC-UV at wavelengths near 260 nm can be used for purity assessment. LC-MS and LC-MS/MS provide greater sensitivity and are often applied to biological samples. Identification typically relies on matching retention time, mass-to-charge ratio, and fragmentation pattern to a reference standard.
NMN is generally handled as a hygroscopic and light-sensitive solid in laboratory settings. Recommended storage is typically at -20°C or below, often under desiccation and protected from light. Aqueous solutions are less stable than the solid and may degrade through hydrolysis or other pathways, so fresh preparation is common for analytical work. Repeated freeze-thaw cycles can reduce sample integrity. Stability depends on pH, temperature, buffer composition, and the presence of metal ions, so specific shelf-life values should be determined experimentally rather than assumed.
Quality control for NMN samples often includes purity determination by HPLC, identity confirmation by mass spectrometry or NMR, and water content measurement by Karl Fischer titration. Certificates of analysis may report residual solvents, heavy metals, and microbial limits depending on the intended use. Purity values are method-dependent, so a stated percentage should be interpreted alongside the analytical procedure and detection wavelength. Reference standards help ensure that retention times and spectral data are comparable across laboratories. Researchers increasingly request independent verification because supply chains for specialty chemicals can vary in documentation.
Quantifying NMN requires methods that separate it from structurally similar compounds such as nicotinamide, nicotinamide riboside, and NAD+. Common approaches include high-performance liquid chromatography coupled with ultraviolet detection, liquid chromatography with tandem mass spectrometry, capillary electrophoresis, and nuclear magnetic resonance for identity confirmation. Because NMN is polar and often present at low concentrations in biological samples, sample preparation can involve protein precipitation, solid-phase extraction, or derivatization. Isotope-labeled internal standards help correct for matrix effects and recovery losses. Reported concentrations depend heavily on the matrix, extraction protocol, and analytical platform.
Stability of NMN depends on physical form, temperature, moisture, light, and pH. The solid compound is generally more stable than aqueous solutions, which can degrade over time, especially when warm or exposed to extreme pH. Recommended laboratory storage is typically desiccated at −20 °C or below, protected from light, with containers sealed to limit moisture uptake. In solution, degradation products may include nicotinamide and related ribosides, and the rate varies with buffer composition and concentration. Analytical laboratories often prepare fresh solutions and validate stability for each method.
Risks arising from their use should not exceed the threshold of 'maximum acceptable risks'. The new implementing regulations seek to specify this threshold." While devices for neurostimulation with an intended medical purpose require a pre-market approval, their direct-to-consumer products are only subjected to the CE marking of conformity. The EU lacks specific regulations and directives dedicated to neurotechnologies. Therefore, any physician, nurse, psychologist, occupational therapist, or specialist in neurotechnology and bioengineering may conduct neurotherapy. In the United States, the Food and Drug Administration (FDA) does not regulate neurotherapy (since it is the practice of medicine). "Licenses—such as those for physicians, registered nurses, and dentists—are typically obtained after providing evidence of education and training; some require proof of passing written and/or clinical exams. Licenses allow individuals to provide a specific set of services that are considered to be within the limits of one's field, or "scope of practice". That is, licenses, for example, for physicians and registered nurses, allow them to practice neurotherapy that is considered within their area of specialty or scope of practice.
=== Pharmaceuticals === Pharmaceuticals are gaining more attention as Contaminants of emerging concern (CECs) because of their continual release into the environment, their persistence and their general lack of regulation. These compounds are often present at low concentrations in water bodies and little is currently known about their environmental and health effects from chronic exposure; pharmaceuticals are only now becoming a focus in toxicology due to improved analytical techniques that allow very low concentrations to be detected. The main source of pharmaceutical pollution in the environment is effluent from wastewater treatment plants, aquaculture and agricultural runoffs. Once present in the environment, pharmaceuticals can cause long-term ecological and health effects such as synthetic estrogens from contraceptives that have led to feminization in male fish, and anti-inflammatory drugs Despite their ubiquity in the environment, pharmaceuticals remain largely unregulated in most environmental statutes.
Robert Schleip (born 1954) is a German psychologist, human biologist and author, best known for his work in the field of fascia. He serves as the director of the Fascia Research Group, a research collaboration between the University of Ulm and the Technical University of Munich. Schleip is also the founding director of the Fascia Research Society, the research director of the European Rolfing Association and vice president of the Ida P. Rolf Research Foundation. He is involved in the alternative medicine field of rolfing.
Sources: en.wikipedia.org
== Diode Array UV-VIS Detectors == In recent years, diode array UV-Vis detectors have been increasingly used to collect entire spectra at any given moment of data collection. Diode array detectors (DADs) collect entire UV spectra at every point of the eluting peaks while operating as a multi-wavelength UV-Vis detector. This way they give additional information, which help understand more about the nature of the substances appearing in the chromatogram and allow their identification. DADs are the preferred detectors for HPLC method development because they facilitate better peak identification.
These passages include the questioning of Jesus as to whether he is Elijah, John the Baptist, Jeremiah, or another prophet (Matthew 16:13–15 and John 1:21–22) and, less clearly (while Elijah was said not to have died, but to have been taken up to heaven), John the Baptist being asked if he is not Elijah (John 1:25). Around the 11–12th century in Europe, several reincarnationist movements were persecuted as heresies, through the establishment of the Inquisition in the Latin Christendom. These included the Cathar, Paterene or Albigensian church of western Europe, the Paulician movement, which arose in Armenia, and the Bogomils in Bulgaria. Christian sects such as the Bogomils and the Cathars, who professed reincarnation and other gnostic beliefs, were referred to as "Manichaean", and are today sometimes described by scholars as "Neo-Manichaean". As there is no known Manichaean mythology or terminology in the writings of these groups there has been some dispute among historians as to whether these groups truly were descendants of Manichaeism.
An ingredient is added to this list when it is excluded from use in a dietary supplement, does not appear to be an approved food additive or recognized as safe, and/or is subjected to the requirement for pre-market notification without having a satisfied requirement.
Density: 0.180 kg/m3 at STP (0 °C, 101325 Pa). Atomic weight: 2.0141017926 Da. Mean abundance in ocean water (from VSMOW) 155.76 ± 0.1 atoms of deuterium per million atoms of all isotopes of hydrogen (about 1 atom of in 6420); that is, about 0.015% of all atoms of hydrogen (any isotope) Data at about 18 K for 2H2 (triple point):
Sources: en.wikipedia.org
NMN is often measured by high-performance liquid chromatography with ultraviolet detection. Liquid chromatography-tandem mass spectrometry can provide greater sensitivity and specificity. The chosen method should be validated and compared against a certified reference standard when possible.
Cool temperatures slow chemical reactions that can degrade NMN over time. Moisture and light can also promote breakdown, so desiccated and light-protected containers are common. Storage recommendations may differ for dry powder and prepared solutions.
Related substances may include nicotinamide, nicotinamide riboside, and NAD+. Residual solvents or inorganic impurities can also be present depending on the manufacturing process. Purity testing aims to identify and limit these substances.
Purity is commonly measured by high-performance liquid chromatography with ultraviolet or mass spectrometric detection. Nuclear magnetic resonance can confirm identity and anomeric composition. Water content and residual solvents may be tested separately.